MedTrace Logo

Prandial Insulin Dosing in Hospitalized Patients

NCT01101867 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2018-01-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.

Conditions

  • Diabetes
  • Admitting Hospital
  • Non-critically Ill

Interventions

DRUG

Aspart fixed dose

fixed dose

DRUG

Aspart flexible dose

dose based upon carbohydrate intake and total daily requirements

Sponsors & Collaborators

Principal Investigators

  • Kathleen M Dungan, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-06-30
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101867 on ClinicalTrials.gov